NCT02549352View on ClinicalTrials.gov

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up

PHASE3CompletedINTERVENTIONAL
Enrollment

391

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

September 22, 2016

Study Completion Date

August 31, 2017

Conditions
Actinic Keratosis
Interventions
DRUG

LEO43204 gel

DRUG

Vehicle gel

Trial Locations (1)

45657

Klinik für Dermatologie & Allergologie Klinikum Vest GmbH, Recklinghausen

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY